We are live on ! Find out more
PLX icon

Protalix BioTherapeutics
PLX

47 hedge funds and large institutions have $156M invested in Protalix BioTherapeutics in 2013 Q2 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.41% more ownership

Funds ownership: 0% → 3.41% (+3.4%)

74% less call options, than puts

Call options by funds: $599K | Put options by funds: $2.31M

Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
1.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
47
Increased
–
Reduced
–
Closed
–
Calls
$599K
Puts
$2.31M
Net Calls
-$1.72M
Net Calls Change
-$1.72M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NSEDCP
26
NJ State Employees Deferred Compensation Plan
New Jersey
$196K +$212K +4,000 New
FMBTD
27
First Midwest Bank Trust Division
Illinois
$183K +$198K +3,723 New
ARTA
28
A.R.T. Advisors
New York
$181K +$197K +3,706 New
Two Sigma Investments
29
Two Sigma Investments
New York
$177K +$191K +3,596 New
CD
30
Carl Domino
Florida
$137K +$149K +2,800 New
PVH
31
Psagot Value Holdings
Israel
$121K +$131K +2,461 New
Group One Trading
32
Group One Trading
Illinois
$112K +$121K +2,288 New
Millennium Management
33
Millennium Management
New York
$84K +$90.5K +1,705 New
Citadel Advisors
34
Citadel Advisors
Florida
$79K +$85.7K +1,616 New
CCA
35
Catalyst Capital Advisors
New York
$74K +$79.6K +1,500 New
Jane Street
36
Jane Street
New York
$64K +$68.9K +1,298 New
Two Sigma Advisers
37
Two Sigma Advisers
New York
$64K +$70.5K +1,329 New
HM
38
Harvest Management
New York
$49K +$53.1K +1,000 New
VanEck Associates
39
VanEck Associates
New York
$49K +$53.5K +1,008 New
BJ
40
BlackRock Japan
Japan
$48K +$51.7K +975 New
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$39K +$41.6K +784 New
SGAM
42
Smith Group Asset Management
Texas
$23K +$24.4K +459 New
Bank of America
43
Bank of America
North Carolina
$4K +$3.82K +72 New
Citigroup
44
Citigroup
New York
$4K +$4.67K +88 New
TRCT
45
Tower Research Capital (TRC)
New York
$2K +$2.07K +39 New
Barclays
46
Barclays
United Kingdom
$1K +$1.06K +20 New
Ameriprise
47
Ameriprise
Minnesota
– +$159 +3 New
1
2

PLX Hedge Fund Activity: Q2 2013 in Review

47 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Protalix BioTherapeutics (PLX) for Q2 2013, worth a combined $156M.

Buyers outnumbered sellers: 47 funds opened new PLX positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

  • 47 institutional investors held Protalix BioTherapeutics (PLX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $156M of Protalix BioTherapeutics stock for Q2 2013.
  • 47 funds opened new Protalix BioTherapeutics positions in Q2 2013 and 0 closed out, a net change of +47 holders.

Based on aggregated 13F filings for Q2 2013.